QSAM Biosciences Shares Rise 37% After Merger Term Sheet With Telix Pharma

By Chris Wack QSAM Biosciences shares were up 37% at $7 after the company signed a non-binding merger term sheet with Telix Pharmaceuticals (US), a...

Related Keywords

Chris Wack ,Telix Pharmaceuticals Ltd ,Telix Pharmaceuticals ,Contingent Value Rights ,Article Normal ,Biotechnology Services ,Pharmaceuticals ,Detergent Cleaning Products ,Healthcare Life Sciences ,Biopharmaceuticals ,Consumer Goods ,Nondurable Household Products ,Financial Performance ,Share Price Movement Disruptions ,Ownership Changes ,Acquisitions Mergers Shareholdings ,Acquisitions Mergers ,Corporate Actions ,Corporate Industrial News ,Mergers ,Equity Markets ,Commodity Financial Market News ,Content Types ,Factiva Filters ,C Amp Ampe Exclusion Filter ,C Amp Ampe Industry News Filter ,Synd ,Tlx Au ,Au Tlx ,Qsam Biosciences ,Qsam ,Share Price Movement ,Disruptions ,Acquisitions ,Shareholdings ,Corporate ,Industrial News ,Commodity ,Financial Market News ,Detergent ,Cleaning Products ,Healthcare ,Life Sciences ,